Data / Drug companies / Bisoprolol fumarate
Bisoprolol fumarate: 25 companies and 49 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bisoprolol fumarate is listed in the FDA National Drug Code Directory by 25 companies, with 49 products in commercial distribution. 49 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on June 1, 2026.
The request: Get every company that lists bisoprolol fumarate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 25
- Products
- 49
- Generic (ANDA) products
- 49 (100.0%)
- Application numbers
- 12
- Routes
- Oral
- Brand names
- Bisoprolol
- openFDA record search
- api.fda.gov
Companies that list bisoprolol fumarate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | October 29, 2021 |
| Advagen Pharma Ltd | 3 | tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| TruPharma, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Alembic Pharmaceuticals Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | September 11, 2019 |
| Alembic Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | September 11, 2019 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 29, 2021 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | December 27, 2006 |
| Bryant Ranch Prepack | 2 | tablet; tablet, film coated | Generic drugs (ANDA) | June 20, 2019 |
| Golden State Medical Supply, Inc. | 2 | tablet | Generic drugs (ANDA) | October 29, 2021 |
| Harman Finochem Limited | 2 | tablet | Generic drugs (ANDA) | May 12, 2024 |
| Micro Labs Limited | 2 | tablet, film coated | Generic drugs (ANDA) | June 1, 2026 |
| Natco Pharma USA LLC | 2 | tablet | Generic drugs (ANDA) | November 25, 2024 |
| NorthStar Rx LLC | 2 | tablet, film coated | Generic drugs (ANDA) | December 27, 2006 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 10, 2024 |
| Rising Pharma Holdings, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | July 11, 2025 |
| Solco Healthcare US, LLC | 2 | tablet | Generic drugs (ANDA) | July 5, 2022 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | March 10, 2024 |
| Unichem Pharmaceuticals (USA), Inc. | 2 | tablet | Generic drugs (ANDA) | September 21, 2009 |
| Viona Pharmaceuticals Inc | 2 | tablet, film coated | Generic drugs (ANDA) | September 15, 2022 |
| Zydus Lifesciences Limited | 2 | tablet, film coated | Generic drugs (ANDA) | September 15, 2022 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | April 20, 2023 |
| AvPAK | 1 | tablet, film coated | Generic drugs (ANDA) | January 10, 2022 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | June 20, 2019 |
| Preferred Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | May 21, 2024 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 21, 2009 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 31 | 63.3% |
| Tablet | 18 | 36.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 49 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 49 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.